T lymphocyte apoptosis in systemic lupus erythematosus patients

Iranian Journal of Basic Medical Sciences

Volumn 16, Issue 8, 2013, Pages 936-941

  Rastin, Maryam ^a   Mahmoudi, Mahmoud ^a   Hatef, Mohammadreza ^b   Sahebari, Maryam ^c   Tabasi, Nafiseh ^a   Haghmorad, Dariush ^a   Nosratabadi, Reza ^a   Zamani, Shahrzad ^a   Khazaee, Mahdieh ^a   Masoudian, Mitra ^a  

^a MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Apoptosis; Autoimmune; Gene expression; Systemic lupuserythematosus

Indexed keywords

CASPASE 8; CASPASE 9; FAS ANTIGEN; FAS LIGAND; LIPOCORTIN 5; PROTEIN BCL 2;

ADOLESCENT; ADULT; APOPTOSIS; ARTICLE; CELL ISOLATION; CELL SELECTION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; HUMAN CELL; MALE; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE;

EID: 84884994080     PISSN: 20083866     EISSN: 20083874     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Arbuckle MR, McClain MT, Rubertone MV, Scofield RH, Dennis GJ, James JA, et al. Development of auto antibodies before the clinical onset of systemic lupus erythematosus. N Engl J Med 2003; 349: 1526-1533.
2. Xue C, Lan-Lan W, Bei C, Jie C, Wei-Hua F. Abnormal Fas/FasL and caspase-3-mediated apoptotic signaling pathway of T lymphocyte subset in patients with systemic lupus erythematosus. Cell Immunol 2006; 239: 121-128.
3. Kaplan MJ. Apoptosis in systemic lupus erythematosus. Clin Immunol 2004; 112: 210-218.
4. Wang H, Xu J, Ji X, Yang X, Sun K, Liu X, et al. The abnormal apoptosis of T cell subsets and apoptosis involvement of IL-10 in systemic lupus erythematosus. Cell Immunol 2005; 235: 117-121.
5. Munoz L, Bavel CV, Franz S, Berden J, Hermann M, Van der Vlag J. apoptosis in the pathogenesis of systemic lupus erythematosus. Lupus 2008; 17: 371-375.
6. Reefman E, Horst G, Nijk MT, Limburg PC, Kallenberg CGM, and Bijl M. Opsonization of Late Apoptotic Cells by Systemic Lupus Erythematosus Autoantibodies Inhibits Their Uptake via an Fcγ Receptor-Dependent Mechanism. Arthritis Rheum 2007; 56: 3399-3341.
7. Bijl M, Limburg PC, Kallenberg CG. New insight into the pathogenesis of systemic lupus erythematosus (SLE): the role of apoptosis. N J Med 2001; 59: 66-75.
8. Bijl M, Horst G, Limburg PC, Kallenberg CG.Anti-CD3-induced and anti- Fas -induced apoptosis in systemic lupus erythematosus. Clin Exp Immunol 2001; 123: 127-132.
9. Zimmermann KC, Bonzon C, Green DR.The machinery of programmed cell death. Pharmacol Ther 2001; 92: 57-70.
10. Bengtsson AA, Gullstrand B, Truedsson L, Sturfelt G.SLE serum induces classical caspase-dependent apoptosis independent of death receptors. Clin Immunol 2008; 126: 57-66.
11. Krueger A, Fas SC, Baumann S, Krammer PH.The role of CD95 in the regulation of peripheral T-cell apoptosis. Immunol Rev 2003; 193: 58-69.
12. Caricchio R, Cohen PL. Spontaneous and induced apoptosis in systemic lupus erythematosus: multiple assays fail to reveal consistent abnormalities. Cell Immunol 1999; 198: 54-60.
13. Grondal G, Traustadottir KH, Kristjansdottir H, Lundberg I, Klareskog L, Erlendsson K, et al.Increased lymphocyte apoptosis/ necrosis and IL-10 producing cells in patients and their spouses in Icelandic systemic lupus erythematosus multicase families. Lupus 2002; 11: 435-442.
14. Courtney PA, Crockard AD, Williamson K, McConnell J, Kennedy RJ, Bell AL. Lymphocyte apoptosis in systemic lupus erythematosus: relationship with Fas expression, serum soluble Fas and disease activity. Lupus 1999; 8: 508-513.
15. Lorenz HM, Grunke M, Hieronymus T, Hermann M, Kuhnel A, Manger B, et al. In vitro apoptosis and expression of apoptosis- related molecules in lymphocytes from patients with systemic lupus erythematosus and other autoimmune diseases. Arthritis Rheum 1997; 40: 306-317.
16. Ho CY, Wong CK, Li EK, Lam WK. Effects of dexamethasone on the expression of Fas molecules and apoptosis of lymphocytes in patients with systemic lupus erythematosus. Immunol Invest 2001; 30: 231-43.
17. McNally J, Yoo DH, Drappa J, Chu JL, Yagita H, Friedman SM, et al.Fas ligand expression and function in systemic lupus erythematosus. J Immunol 1997; 159: 4628-4636.
18. Maas K, Chan S, Parker J, Slater A, Moore J, Olsen N, et al. Cutting edge; molecular portrait of human autoimmune disease. J Immunol 2002; 169: 5-9.
19. Kovacs B, Liossis SN, Dennis GJ, Tsokos GC. Increased expression of functional Fas-ligand in activated T cells from patients with systemic lupus erythematosus. Autoimmunity 1997; 25: 213-221.
20. Gaipl US, Munoz LE, Grossmayer G, Lauber K, Franz S, Sarter K, et al. Clearance deficiency and systemic lupus erythematosus (SLE). J Autoimmun 2007; 28: 114-121.
21. Grossmayer GE, Munoz LE, Gaipl US, Franz S, Sheriff A, Voll RE, et al. Removal of dying cells and systemic lupus erythematosus. Mod Rheumatol 2005; 15: 383-390.
22. Shao WH, Cohen PL. Disturbances of apoptotic cell clearance in systemic lupus erythematosus. Arthritis Res Ther 2011; 13: 202.
23. Rastin M, Hatef MR, Tabasi N, Mahmoudi M. The pathway of estradiol- induced apoptosis in patients with systemic lupus erythematosus. Clin Rheumatol 2012; 31: 417-424.
24. Rastin M, Hatef MR, Tabasi N, Sheikh A, Morad Abbasi J, Mahmoudi M. Sex hormones and peripheral white blood cells in systemic lupus erythematosus. Iran J Immunol 2007; 4: 110-115.
25. Zandman-Goddard G, Peeva E, Shoenfeld Y. Gender and autoimmunity. Autoimmun Rev 2007; 6: 366-372.